Osteoporosis in Type 2 diabetes
Conditions
Interventions
Type 2 diabetes group vs normal group:N/A
Sponsors
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Adult patients admitted to the Department of Endocrinology and metabolism of Ruijin Hospital from January 1, 2010 to December 31, 2018; 2. The results of OGTT test were in accordance with WHO diagnostic criteria for diabetes in 1999, or were diagnosed as type 2 diabetes in the past.
Exclusion criteria
Exclusion criteria: 1. Endocrine and metabolic diseases: type 1 diabetes, hypogonadism, Cushing syndrome, primary aldosteronism, pheochromocytoma, acromegaly, hyperthyroidism, hypothyroidism, hyperparathyroidism, hypoparathyroidism, functional pituitary tumor, etc; 2. Diseases affecting bone metabolism: rheumatoid arthritis, systemic lupus erythematosus, etc autoimmune diseases , chronic kidney disease stage 4 and 5 (EGFR < 30 ml / min); 3. Medications or agents affecting bone metabolism: thiazolidinediones, calcitonin, glucocorticoids, bisphosphonates, etc; 4. Pregnancy, or malignant diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fracture(s); | — |
Secondary
| Measure | Time frame |
|---|---|
| change in BMDs;L1-4 BMD;L1-4 BMD T score;L1-4 BMD Z score;L2-4 BMD;L2-4 BMD T score;L2-4 BMD Z?;Femoral neck BMD;Femoral neck BMD T score;Femoral neck BMD Z score;Femur Wards BMD;Femur Wards BMD T score;Femur Wards BMD Z score;Femur troch BMD;Femur troch BMD T score;Femur troch BMD Z?;Femur shaft BMD;Femur shaft BMD T score;Femur shaft BMD Z score;Total Hip BMD;Total Hip BMD T score;Total Hip BMD Z score; | — |
Countries
China
Contacts
Public ContactTao Bei
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Outcome results
None listed